![](/img/cover-not-exists.png)
PCN71 COST-EFFECTIVENESS (CE) ANALYSIS OF ERBB2-TARGETED THERAPIES IN WOMEN WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ METASTATIC BREAST CANCER (MBC) AND LIMITED EXPOSURE TO PRIOR CHEMOTHERAPY (CT)
T Delea, O Sofrygin, P Tappenden, D Browning, MM Amonkar, J Karnon, K LykopoulosVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73308-8
File:
PDF, 91 KB
english, 2009